We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
PETS Q2 2026 Earnings: Narrow EPS Miss Weighs on Shares as PetMed Express Faces Margin Pressures - Guidance Revision Trend - dars.gov.et
PETS Q2 2026 Earnings: Narrow EPS Miss Weighs on Shares as PetMed Express Faces Margin Pressures - Guidance Revision Trend dars.gov.et
PETS Q2 2026 Earnings: EPS Misses Estimates by 3.49% as Losses Persist - Operating Income Trends - dars.gov.et
PETS Q2 2026 Earnings: EPS Misses Estimates by 3.49% as Losses Persist - Operating Income Trends dars.gov.et
PetMed Express stock. Focus turns to the business model. - ad-hoc-news.de
PetMed Express stock. Focus turns to the business model. ad-hoc-news.de
PetMed Express considers revised buyout bid as Singapore-based investor presses for sale - The Business Journals
PetMed Express considers revised buyout bid as Singapore-based investor presses for sale The Business Journals
PETS Q2 2026 Earnings: EPS Misses Estimates as Stock Rallies - Guidance Upgrade Report - dars.gov.et
PETS Q2 2026 Earnings: EPS Misses Estimates as Stock Rallies - Guidance Upgrade Report dars.gov.et
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2026 Q3 | 2024. 12. 31. | Time TBD | — | $0.26 | — | — | $176.21M | Reported |
| FY2026 Q2 | 2024. 09. 30. | Time TBD | — | $0.29 | — | — | $124.25M | Reported |
| FY2026 Q1 | 2024. 06. 30. | Time TBD | — | $0.18 | — | — | $66.21M | Reported |
| FY2025 Q3 | 2023. 12. 31. | Time TBD | — | $-0.12 | — | — | $214.56M | Reported |
No research actions to show.
As of FY2026Q3 · Source: SEC/DART + price data
No holdings data to show.